Skip to content
Skip to main navigation
Skip to 1st column
Skip to 2nd column
Marijuana in Combination with Opioids for Cancer Pain
Donald Abrams, M.D.
Cannabis for Spasticity/Tremor in MS: Placebo Controlled Study
Mark Agius, M.D.
Cannabinoids in Fear Extinction
Mark Barad, M.D., Ph.D.
Treating Chemotherapy-Induced Delayed Nausea with Cannabinoids
Suzanne Dibble, DNSc, RN
MMJ for HIV-associated DSPN: Adherence & Compliance Sub-Study
Dennis Israelski, M.D.
Analgesic Efficacy of Smoked Cannabis in Refractory Cancer Pain
Mark Wallace, M.D.
Studies Under Review
New in Cannabinoid Research
Separate and combined effects of gabapentin and [INCREMENT]9-tetrahydrocananbinol in humans discriminating [INCREMENT]9-tetrahydrocananbinol.
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms.
Cannabinoids and Schizophrenia: Risks and Therapeutic Potential.
Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats.
New in Cannabinoid Trials
Trial of Dronabinol and Vaporized Cannabis in Neuropathic Low Back Pain
Cannabinoid Profile Investigation of Vapourized Cannabis in Patients With Osteoarthritis of the Knee
Effects of Cannabis Administration Routes on Human Performance and Pharmacokinetics
Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?
Cannabis Effects on Driving-related Skills of Young Drivers
Copyright ©2010 CENTER FOR MEDICINAL CANNABIS RESEARCH |
University of California, San Diego
| contact the